Early bone SPECT/CT for prediction of prognosis in patients with castration resistant prostate cancer treated with 223 Ra

被引：0
|
作者：
Paone, G. [1 ]
Ceriani, L. [1 ]
Ruberto, T. [1 ]
Treglia, G. [1 ]
Giovanella, L. [1 ]
机构：
[1] Oncol Inst Southern Switzerland, Lugano, Switzerland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP337
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [1] The Prognostic Value of Quantitative Bone SPECT/CT Before 223Ra Treatment in Metastatic Castration-Resistant Prostate Cancer
    Dittmann, Helmut
    Kaltenbach, Sabine
    Weissinger, Matthias
    Fiz, Francesco
    Martus, Peter
    Pritzkow, Maren
    Kupferschlaeger, Juergen
    la Fougere, Christian
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (01) : 48 - 54
  • [2] Feasibility and efficacy of 223Ra-dichloride (223Ra) to treat bone metastases in patients (pts) with castration resistant prostate cancer (mCRPC)
    Farnesi, A.
    Mazzarri, S.
    Boni, G.
    Galli, L.
    Cianci, C.
    Borso', E.
    Marconcini, R.
    Biasco, E.
    Derosa, L.
    Sbrana, A.
    Antonuzzo, A.
    Ricci, S.
    Volterrani, D.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 62 - 62
  • [3] RADIUM RA 223 DICHLORIDE IN CASTRATION-RESISTANT PROSTATE CANCER
    Joung, J. Y.
    Ha, Y-S.
    Kim, I. Y.
    DRUGS OF TODAY, 2013, 49 (08) : 483 - 490
  • [4] Diagnostic impact of quantitative bone SPECT/CT for patients with bone metastasis caused by castration resistant prostate cancer
    Fukushima, Y.
    Kumita, S.
    Kimura, G.
    Akatsuka, J.
    Hamana, T.
    Sugihara, Y.
    Ando, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S737 - S737
  • [5] Radium-223 (Ra-223) in asymptomatic metastatic castration-resistant prostate cancer (mCRPC) patients treated in an international early access program (iEAP).
    Heidenreich, Axel
    Gillessen, Silke
    Heinrich, Daniel
    Keizman, Daniel
    O'Sullivan, Joe M.
    Carles, Joan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [6] Ra-223 alpha-Therapy in Patients with Bone Metastases from Castration-resistant Prostate Cancer
    Jessome, Rebecca
    JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES, 2015, 46 (02) : 156 - 161
  • [7] Predictive and Prognostic 18F-Fluorocholine PET/CT Radiomics Nomogram in Patients with Castration-Resistant Prostate Cancer with Bone Metastases Treated with 223Ra
    Cruz-Montijano, Marcos
    Amo-Salas, Mariano
    Cassinello-Espinosa, Javier
    Garcia-Carbonero, Iciar
    Villa-Guzman, Jose Carlos
    Garcia-Vicente, Ana Maria
    CANCERS, 2024, 16 (15)
  • [8] Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program
    Axel Heidenreich
    Silke Gillessen
    Daniel Heinrich
    Daniel Keizman
    Joe M. O’Sullivan
    Joan Carles
    Manfred Wirth
    Kurt Miller
    John Reeves
    Monica Seger
    Sten Nilsson
    Fred Saad
    BMC Cancer, 19
  • [9] Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program
    Heidenreich, Axel
    Gillessen, Silke
    Heinrich, Daniel
    Keizman, Daniel
    O'Sullivan, Joe M.
    Carles, Joan
    Wirth, Manfred
    Miller, Kurt
    Reeves, John
    Seger, Monica
    Nilsson, Sten
    Saad, Fred
    BMC CANCER, 2019, 19 (1)
  • [10] Evolutionary assesssment with 18F-Fluoride PET / CT in patients with castration-resistant metastatic prostate cancer treated with Ra-223
    Blanco Cano, I. S., Sr.
    Garcia Burillo, A.
    Villasboas Rosciolesi, D.
    Carrillo Villamizar, E.
    Castell Conesa, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S798 - S798
12345